BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2014 11:31:00 AM | Browse: 857 | Download: 946
Publication Name World Journal of Gastroenterology
Manuscript ID 5740
Country China
Received
2013-09-25 09:07
Peer-Review Started
2013-09-25 11:44
To Make the First Decision
2013-10-22 16:42
Return for Revision
2013-10-23 09:50
Revised
2013-11-05 20:29
Second Decision
2014-01-15 20:19
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-01-15 20:35
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-02-22 12:11
Typeset the Manuscript
2014-04-11 10:16
Publish the Manuscript Online
2014-04-17 13:27
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Advances in epigenetic biomarker research in colorectal cancer
Manuscript Source Invited Manuscript
All Author List Xi Wang, Ye-Ye Kuang and Xiao-Tong Hu
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 81071651
National Natural Science Foundation of China 81372622
Program for Zhejiang Leading Team of ST innovation 2012R10046-03
Major State Basic Research Development Program 2010CB834303
National High Technology Research and Development Program of China 2012AA02A601
Major Projects in Zhejiang Province 2012C13014-1
Fundamental Research Funds for the Central Universities 2012FZA7020
Corresponding Author Xiao-Tong Hu, MD, PhD, Biomedical Research Center, Sir Run Run Shaw Hospital, Zhejiang University and Key Laboratory of Biotherapy of Zhejiang Province, Qing Chun East Road 3, Hangzhou 310016, Zhejiang Province, China. hxt_hangzhou@sina.com
Key Words Colorectal cancer; Epigenetic biomarker; DNA methylation; MicroRNA biomarker; Histone modification
Core Tip Epigenetic biomarkers, including DNA methylation, microRNA expression and histone modification, may have the potential for the screening, diagnosis, prognosis and recurrence surveillance in colorectal cancer patients.
Publish Date 2014-04-17 13:27
Citation Wang X, Kuang YY, Hu XT. Advances in epigenetic biomarker research in colorectal cancer. World J Gastroenterol 2014; 20(15): 4276-4287
URL http://www.wjgnet.com/1007-9327/full/v20/i15/4276.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i15.4276
Full Article (PDF) WJG-20-4276.pdf
Full Article (Word) WJG-20-4276.doc
Manuscript File 5740-Review.doc
Answering Reviewers 5740-Answering reviewers.pdf
Copyright License Agreement 5740-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 5740-Language certificate.pdf
Peer-review Report 5740-Peer reviews.pdf
Scientific Editor Work List 5740-Scientific editor work list.doc